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renee of multilevel disease in Cl.I patients has already been alluded to and discussed in terms of
the need for concomitant distal bypass. However, combinations of endovascular and surgical
procedures are increasingly being employed. Combined endovascular/surgical procedures have
had some success in this regard. In considering the approach to a combined procedure, either
concurrently in the operating room or sequentially in the angiography suite with early subse-
quent bypass, each lesion must be considered on its own merit. Iliac artery dilatation to improve
inflow for a cross-femoral graft has been reported to be successful in carefully selected
patients.l-s Those patients with pressure gradients across aortoiliac stenoses should have these
corrected before construction of a distal bypass graft.
For suitable lesions, balloon angioplasty, performed either intraoperatively or preoperatively, pro-
vides adequate inflow to maintain the distal reconstruction. The quality of the endovascular and
surgical components of the technique must not be compromised by skills and training of the
individual performing either part of the procedure. Also, in the absence of sufficient length of
ideal conduit tor a distal bypass, balloon angioplasty may remove a discrete lesion distally, per-
mitting longer-term patency of an otherwise compromised graft. The determination of combin-
ing or performing the procedures sequentially will be determined by local circumstances.
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D 4.8 Infrainguinal Disease-Surgical Treatment
The main guiding principles behind surgical reconstruction are to bypass into the best available
outflow vessel possible regardless of the anatomic level and to construct the bypass graft with
autogenous vein. Further explanation and exceptions to these principles are discussed in the fol-
lowing sections. The issue of above-knee femoropopliteal bypass grafting has been addressed earli-
er (see B 4.4, Surgery for Intermittent Claudication, p SI13). When a bypass graft is constructed
to an outflow artery below the knee, autogenous tissue is accepted as the preferred conduit.
D 4.8.1 Inflow
Before reconstruction of infrainguinal PAD, the surgeon must ensure adequate inflow to the
groin level or site of proximal anastomosis (see also Recommendation 88, p S210). The
common femoral artery or an inflow graft is the usually accepted origin of a femoral distal
bypass graft. A number of authors have reviewed experience with more distal take-off of
bypass grafts (profunda, SFA, popliteal) and have found that in appropriately chosen individ-
uals there is no compromise to the bypass. 1,2,3 For example, a stenosis of20% or more in the
native superficial femoral artery proximal to a graft origin has been correlated with eventual
graft failure.! Because atherosclerosis is a generalized and in many cases progressive disease,
distal origin bypass grafts should be undertaken only when inflow to that level is uncornpro-
mised. This issue is of some importance when alternative (and presumably shorter) segments
of vein must be used for bypass grafts.
Recommendation 89: Inflow artery for femorodistal bypass
Any artery, regardless of level (ie, not only the common femoral artery), may serve as an
inflow artery for a distal bypass provided that flow to mat artery and the origin of the
graft is uncompromised.
8218 D4 Treatment ofCriticnl Limb Ischemia
JOURNAL OF VASCULAR SURGERY
January 2000
D 4.8.2 Outflow (Run-off) Arteries
The guiding principle here is to choose the distal outflow artery that allows the best perfusion
of the foot. Any distal artery, including the pedal artertes, m-a)' serve -as 0. s\.\\\-a'o\e ou\1\o'N \!.-ac..\.
with acceptable expected patency rates:\'S 'Tne fCSU\ts at kmoro-'oe\Cl'N-mee \lo\l\'\'\.e'd.\. ~'ta.fu,,"~
are similar to femoral distal bypass grafting. 'The CnOteC at me s\te 0\ -me &.st'd.\. <I.\l.<l.s\.omo"'\'"
should be based on the quality of the distal artery and its runoff and not the kngili aT tne
bypass. The main exceptions to this relate to the lack of adequate length of suitable vein.
D 4.8.3 Distal Bypass Grafts
The same principles as outlined in the previous section on femoral-popliteal lesions apply to
more distal bypass grafts. The increased length of the required conduit introduces some special
problems in the absence of long saphenous vein, and these are discussed in the following sec-
tions. There should be no effort to compromise tlle length of bypass just to have the distal anas-
tomosis in the popliteal artery rather than a distal artery. The best distal artery should be select-
ed, because this will give the best long-term patency rates.
Recommendation 90: Femorofemoral distal bypass outflow vessel
In a femoral crural bypass, the least diseased distal artery with the best continuous run-
off to the ankle/foot should be used for outflow regardless of location, provided there
is adequate length of suitable vein.
D 4.8.4 Isolated Popliteal Artery Segment
"When there is no direct communication between the popliteal artery and the tibial vessels, this
"isolated popliteal artery" may be used as an outflow tract.v This situation, which usually arises
when there is a shortage of vein, is an exception to the previously discussed guiding principle.
The indication for such an operation would be CLI and the absence of sufficient length of suit-
able vein for bypass into a more appropriate vessel. Five-year patency rates for bypasses to an
isolated popliteal segment were reported as PTFE, 55%; saphenous vein, 74%; and limb salvage
rates as PTFE, 56%; and saphenous vein, 79%.7 Suggested requirements for a successful bypass
to the blind popliteal artery were a segment of artery of at least 7 cm and at least one major col-
lateral vessel draining the segment. Large perigeniculate collateral arteries have been used suc-
cessfully as outflow vessels in some patients.f
Recommendation 91: Bypass to an isolated popliteal artery
Bypass to an isolated popliteal artery should be considered as an alternative when no
crural or pedal bypass is possible or realistic (eg, because of shortage of vein). An ade-
quate segment of popliteal artery with collateral outflow to the foot is required to
ensure ongoing patency.
D 4.8.5 Choice of Conduit
(See B 4.4.2, Surgical Procedures, p S114) For infragcniculatc reconstruction, there is gener-
al agreement that the conduit should be constructed of autogenous vein. Good results have
been achieved by a variety of techniques. However, the preferred reconstruction is with ipsi-
lateral long saphenous vein (either in situ or reversed). If this is not available, the preferred
alternatives in order of preference are single-segment venous bypass (contralateral greater
saphenous vein, arm vein, erc.) followed by spliced veins from any source. Finally, composite
or prosthetic grafts with adjunct procedures (vein cuff, distal AV fistula) may be considered,
provided expected patency is sufficiently high to justify patient risk. Basic science and clinical
investigations continue into the development of alternative bypass conduits when autogenous
vein is not available. These include arterial and venous homografts, but additional study is
required to determine their efficacy. Results from a variety of conduits are shown in Table 47,
showing diminishing results as less favorable bypass grafts are used. Direct comparison studies
(in addition to those already shown) are shown in Table 48.
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For bypasses below the knee, autogenous tissue is far superior to any other conduit. A random-
ized control trial comparing PYPE with autogenous vein found significantly improved results in
bypass grafts distal to the knee when vein was used in the reconstruction.P This is confirmed in
a meta-analysis by Hunink (see Table 49, p 5223).10
Initial good results with improved techniques for in situ bypass grafts led to claims of better
long-term patency rates. However, when this technique was compared with reversed saphenous
vein graft, a number of randomized trials failed to support this statement.Uvl- On the contrary,
at 5 years the primary patency rate for in situ bypasses was 46.2%, compared with 68.8% for
reversed bypasses (p < 0.05).12 Such randomized comparisons also reflect problems in compar-
ing the two approaches, such as greater (learning curve) experience needed for in situ bypass
and greater need for secondary procedures to deal with residual arteriovenous fistulas (graft
stenoses being equivalent). In general, the techniques are considered equivalent, with tapering
vein creating a diameter mismatch in infrageniculate bypass being the solitary advantage to in
situ bypass. Although some claim that reversed vein has the advantage that it can be moved to
the required location, antegrade use of dislocated vein after valve disruption holds the same
advantage and can be used to overcome diameter mismatch. However, the secondary patency
rate was comparable in the two groups (71.6% in situ vs 79.4% reversed). This demonstrates the
need for meticulous follow-up of vein bypass grafts.
The quality of the vein can affect the outcome. A saphenous vein is optimal if the vessel wall is
thin, the endothelium intact, and the diameter at least 4 mrn, The length and estimate of the
diameter of available veins is frequently assessed preoperatively with duplex scanning, in the order
of choice (ipsilateral greater saphenous, contralateral greater saphenous, lesser saphenous, and arm
veins). TIns practice and the abandonment of unnecessary disqualificationof patients with coro-
nary disease (ie, "saving" veins for the heart) has greatly increased vein utilization. It has been
found that even those with previous partial greater saphenous removal for vein stripping, or har-
vest for CABG or other bypasses, commonly have sufficient vein left in the same leg for an infrain-
guinal bypass.l-' Those veins that require modification for disease at the time of the original proce-
dure are more apt to require further modification to maintain patency.l4Arm vein is easily accessi-
ble and can provide excellent results over the long term. IS The configuration of the arm vein may
be a total segment of basilic or cephalic vein, which is either reversedor undergoes valve destruc-
tion. An alternative is to use a basilic-cephalic loop with one segment requiring valve lysis.l 6
Composite vein grafts composed entirely of vein but constructed from a number of different
segments or sources have proved adequate conduits. Sources of vein may include remnants of
long saphenous vein, short saphenous vein, and arm vein.I? Some studies report results as good
as single-segment long saphenous vein bypass grafts,18 and others suggest that, although good,
the results are not comparable.l? The results of spliced vein grafts to the popliteal and distal ves-
sels at 4 years arc: primary, 45%, and secondary, 61%. These results are improved if at least some
of the graft is in situ long saphenous vein.2o Although direct comparison trials have not been
performed, this approach would seem better than other alternatives, that is, the other adjunctive
procedures discussed in this section. However, the revision rate to maintain patency is approxi-
mately 20%, and a careful program of surveillance is required to achieve optimum results.
Superficial femoral vein has been suggested as a suitable conduit with veryacceptable patencyrates.
The removal of the superficial femoral vein may be complicated by limb edema, but this generally set-
tles with time and elastic supporr.U Size discrepancy may pose a problem in some patients. However,
patency rates equivalent to those for long saphenous vein bypass graftshave been reported.22,23
Recommendation 92: Femoral below-knee popliteal and distal bypass
An adequate long saphenous vein is the optimal conduit in femoral below-knee popliteal
and distal bypass. In its absence, other good-quality vein should be used.
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D 4.8.6 Other Conduits
Available conduits for femoral popliteal bypass grafts include PTFE, HUV, and Dacron. Results
are varied, and reports tend to be selected case studies. A randomized trial comparing PTFE and
Dacron at the popliteal level gave similar results.24,25 Although some randomized trials have
reported superiority of HUV over PTFE or Dacron with respect to patency, this has not been a
consistent finding26,27,28 and late degenerative changes in HUV with aneurysm formation offse.t
any potential patency advantage.i? The major determinant of graft patency is the type of graft
used, and vein is superior to any prosthesis.30,31
Compositegrafts (prosthetic vein)
When insufficient autologous vein is available for distal bypass grafting, there is a question of
whether there is an advantage to constructing some of the bypass graft with vein (composite
bypass graft) rather than use prosthesis entirely. Most studies show a difference or at least a
trend toward improved patency with composite grafts32,33 but no randomized trial data are
available comparing all prosthetic (with or without vein cuff) with composite grafts. Studies are
difficult to compare because there is usually minimal information regarding the percentage of
the graft that is composed of vein.
D 4.8.7 Role of the Profundaplasty Alone
The role for profundaplasty is well accepted as an adjunct to inflow procedures to maintain graft
patency and reduce the need for subsequent or simultaneous distal reconstruction (see also
Management of Coexisting Infrainguinal Occlusive Disease, p 5209). The role of isolated pro-
fundaplasty is more controversial. Clinical success with such a procedure has been achieved in
49% of patients at 3 years.34 A review of the literature has suggested that requirements for suc-
cess include (1) excellent inflow, (2) a greater than 50% stenosis in the proximal third of the
profunda, and (3) the presence of excellent collateral flow to the tibial vessels in continuity with
a foot with no tissue loss.35 In an attempt to evaluate collateral flow distal to the profundaplasty
as a predictor of success, a high segmental limb pressure gradient across the knee (AK-BK pres-
sure/AKpressure> 0.5) has been found to predict clinical failure. 36 There are no other success-
ful objective predictors of success of isolated profundaplasty.
D 4.8.8 Assessing Run-off
In a large, nonrandomized, retrospective study, Darling et al37 reviewed bypass grafts to the per-
oneal (n = 888) and dorsalis pedis artery (n = 291). No difference was found in patency or limb
salvage at 1 and 5 years between the two groups (5-year secondary patency peroneal, 76%; dor-
salis pedis, 68%). These findings are confirmed by other authors.38,39 Even in the presence of
pedal gangrene, the peroneal artery may be an appropriate outflow tract.40
When performing a bypass for CLI, the outflow vessel must be widely patent, with adequate
run-off, and this principle must not be compromised to shorten the length ofthe bypass. At
least one study has shown that long-term patency may be predicted by the adequacy otthe
pedal arch.t! Three-year pedal artery graft patencies were compared with more proximal crural
bypass grafts and yielded comparable results (82% pedal vs 79% tibial, secondary patency) as wcl!
as yielding comparable limb salvage rates (92% pedal vs 87% tibial).42
A variety of methods exist for the intraoperative assessment of graft flow and run-off resis-
tancey'znpedance. Variable results have been reported from a variety of sophisticated methods of
assessment.43,44,45 Although these methods have been shown to predict patency, they have not
gained widespread acceptance because they require completion ofthe bypass graft before pre-
dicting success. The SVS/ISCVS reporting standards for evaluating run-off resistance, taking
into account a number of factors, has been modified and validated by Peterkin et al46 based on
angiography and multiple linear regression analysis. However, it tends to be less predictive of
vein than prosthetic graft patency, the former faring much better in the face of poor run-off.
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D 4.8.9 Adjuvant Procedures to Improve Patency
At times there is insufficient available autogenous tissue with which to construct a bypass graft.
The results of reinforced PTFE to arteries distal to the popliteal have been reported as 45% and
25% at 2 and 5 years, respectively, but are generally lower. Patency rates were reduced 1£ the
bypass was a secondary procedure or if the pedal arch was not intact. Many other surgeons are
unable to match these results when performing prosthetic distal bypass grafts. The following
sections review adjuvant procedures to improve patency of the disadvantaged (especially pros-
thetic) bypass graft.
Arteriovenous fistula
This procedure has been advocated by some when distal bypass graft is constructed with PTF£.
The principle is to decrease vascular resistance and thereby increase flow in the graft while not
creating a hemodynamically significant steal phenomenon. The two most common types are (1)
the"common ostia," where the artery and vein are sutured in such a fashion that an arteriove-
nous fistula is created at the site of the distal anastornosist? and (2) a separate remote arteriove-
nous fistula constructed distal to the artery-prosthesis anastomosis.48,49
There is a lack of good data to support the use of arteriovenous fistula on a routine basis.
Anecdotal reports of graft patency of 71 % and limb salvage of 83% have been published.fv In a
prospective, randomized study, Hamsho et al51 compared graft patency and limb salvage after
fernoro-infrapopliteal bypass using ePTFE with and without addition of adjuvant arteriovenous
fistula. The differences in cumulative rates of primary patency and limb salvage at 1 year after
operation were not statistically significant (55.2% and 54.1% for patients with arteriovenous fis-
tula compared with 53.4% and 43.2%, respectively, for the control group).50 Follow-up with
duplex scanning suggests that ongoing venous patency is important to the continued function
of the graft.52 Arteriovenous fistula, if used at all, should be reserved for tibial or peroneal
bypasses in those situations with poor run-off or a "disadvantaged graft."
Vein interposition/cuff
Among the adjunct techniques, creating a venous patch or cuff at the distal anastomosis of a
prosthetic graft has been described by a number of authors. Miller53 has described a "silo" con-
figuration, whereas Taylor inserts a patch over just the distal toe of the anastomosis. Tyrrell and
Wolfe 54 have shaped the cuff to improve its configuration (the so-called St Mary's boot). In
1995, Raptis and Miller55 reported the results of primary femoropopliteal PTFE grafting with
and without an interposition vein cuff. There was no difference in the patency rates between
cuffed and direct suture for above-knee popliteal bypass grafts (69% and 68% for cuffed and
direct suture, respectively, at 36 monthsl.w There was, however, an appreciable difference for
the below-knee bypass grafts (57% vs 29%, respectively, at 36 months).55 These figures were
later confirmed by Stonebridge et al56 in a randomized trial. The results supported. the use of an
interposition vein cuff when PTFE grafts were anastomosed to the popliteal artery below the
knee, with 2-year patency rates for cuffed and uncuffed grafts of 52% and 29%, respectively (p =
0.03). A more recent randomized study from Belgium did not support the initial positive results
with the use of vein interposition cuffs.f? A comparison of a current series with historical con-
trols suggests that venous cuffs increase patency for prosthetic grafts carried to crural vessels.58
Further studies are needed to establish the role of adjuvant procedures in femoropopliteal or
femoral crural prosthetic bypass grafts (see Critical Issue 35).
Critical Issue 35: Adjunctive procedures with prosthetic infrainguinal bypass grafts
There is a need to determine whether an adjuvant procedure (such as arteriovenous fis-
tula or vein cuff) significantly improves patency when it is necessary to use a prosthetic
conduit for a femoropopliteal or femoral crural bypass.
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D 4.8.10 Results of Infrainguinal Bypass Grafts
In large studies, the major determinant of long-term graft patency is the type of graft material
used as well as the continued use of tobacco.V One review of a personal series of 2,274 bypass
grafts reports primary patency of in situ grafts as: 1 year, 84%; 5 years, 72%; 10 years, 55%; with
no difference in patency detected when stratified for inflow artery, outflow artery, and length of
bypassf? (see Tables 47 and 48). Average results are shown in Figure 25 on page 5234.
Table 47: Selected results of infrainguinal bypass with various conduits
Operative Primary patency (%) SecondaryPatency (%)
CLl Mortality -,----- ---- -------"-_.._----
Patients (%) (%) 1 y" 2yl's 3 yrs 5 J1'S 1sr 2yrs 3 yrs 5 yrs Comments
Reversedgreater saphenous vein
Rutherford 100 75 63
et al, 198827
Taylor et al, 1990 22 100 75 63
Gentile et al, 199618 268 2 98 83 74 ipsilateral
Han et al, 198561 52 23 85 68
in situ
Belkin et al, 1996 386 100 2 68 80
Feinberg et al, 1990 32 57 97 82 64
Alexander et al, 1996 119 92 1 81
Londrey et al, 199133 61 92 4 -6 72 83 74 74 74
LS Votber
Belkin et al, 199662 168 100 I 66 75 Nonrcversed
Londrey et al, 199133 93 92 4 -6 59 76 68 61 59 Reversed vein
Londrey et al, 199417 169 88 2 78 67 59 52 Single length,
any vein
Myers er :11, 199364 537 43 80 73 Reversed vein
Arm veit'
Chalmers et ai, 199465 42 95 0 46 85 64% infrapopliteal
Harward et ai, 1992 66 43 93 0 67 49 64 34% infrapoplitcal
Harris et ai, 198467 70 83 0 85 72 68 56% infrapopliteal
Myers et al, 199364 49 43 63
Spliced vein
Harris er ai, 198668 54 100 6 58 74 78% tibial
Chang et al, 199520 114 95 4A 72 69 80 77 Part in situ
Londrey et ai, 199417 88 88 2 56 53 39 29
Taylor et ai, 198769 140 81 1.5 95 83 Other vein
Taylor et al, 198769 189 69 1.5 89 84 Partial ipsilateral
vein
Ankle/distal.all vein
Panayiotopoulos et al, 19967°109 100 7 27 45 Crural/pedal
Davidson & Callis, 199371 75 100 6 89 79 68 93 82 70 All vein to foot
Quinones- 46 100 0 72 72 Distal ankle
Baldrich et al, 1993 72
Shall et al, 199659 487 91 3.5 83 70 89 77
Compositepartial prosthesis
Fichelle et al, 1995 73 145 100 3.3 41 35
McCarthy et al, 1992 74 67 100 0 72 64 48 64 40 Sequential 100%
infrapopliteal
DeMasi & Snyder, 1995 75 85 99 22 47 85% infrapopliteal
Feinberg et al, 199032 108 97 35 30 -6
Londrey et al, 199)33 45 92 4 26 55 50 44 28
Alexander et ai, 199663 35 92 35 50
Distal prosthesis
Schweiger et ai, 199341 211 100 3.3 37 23 45 25 100% infrapop-
liteal
Londrey et al, 199)33 33 92 4 7 63 38 26 7
D 4.8.11 Results of Femoropopliteal Bypass Grafts
A meta-analysisperformed by Hunink and colleaguesl" involved strict entry criteria, which per-
mitted pooling of data with reanalysis of stratified categories of patients. Papers published
between 1983 and 1995 were included if they were original reports not duplicating previous
data, included the numeric data for the Kaplan-Meier analysis, defined patency as hemodynamic
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Table 48: Selected results of comparative studies of infrainguinal bypass grafts
Operativ«
Patients CLI (%) mortality (%)
______l)Lny!!J'jJfllCJ1fJ'--(J'eL __
l~ 3F 4F SF Comments
> 90% lnfrapapliteal compariscns-r-all studies
Vein type
Taylor et ai, 199060 285 80 1 89
231 80 1 84
Gentile et al, 199618 268 2 98
58 2 85
133 1 83
Distal anastomosis
Donaldson er al, 199176 440 68 87
299 100 2 83
240 91
200 82
Graft type
Veith er al, 19869 106 86 6
98 88 4
Cranley & Hafner, 198277 40 100 2 59
13 100 33
Edwards & Mulherin, 198078 57 88 82
29 93 21
15 93 7
Rutherford et al, 198827 50 98 88
22 100 75
14 71 25
21 95 7
Hall et al, 198561 52 23 85
27 48 63
47 62 54
84
71
83
82
75
84
81
86
81
88
63
17
7
68
49
34
49
12
80
68
74
82
72
83
81
86
78
GSV
other vein
ipsilateral GSV
contralateral GSV
other vein
all grafts
CLI only
popliteal
anastomosis
distal anastomosis
any vein
PTFE
any vein
HUY
any vein
PTFE
HUY
in situ GSV
reversed GSV
PTFE
HUY
RSV
Composite
PTFE
improvement, and reported the distribution of covariates. The reanalysis of 2,060 patients surgi-
cally treated allowed for the assessment of 1,572 patients with CLI. Overall results of femoral
distal bypass reports for CLI are depicted in Table 49, showing a clear advantage for vein
bypass grafts.I"
A review of reports of the results of infrainguinal revascularization procedures published
between 1981 and 1990 was performed by Dalman and Taylor (Table 50).79 Although limited
information is given about inclusion criteria, analysis techniques, or the raw data, they have con-
firmed the superiority of autogenous tissue in infrainguinal bypass. The previous comments
comparing in situ and reversed vein should be considered before accepting the superiority of
one over the other (see D 4.8.5, Choice of Conduit, p 5218).
Table 49: Summary of results of a meta-analysis offemoropopliteal bypass grafts (criticallimb ischemia only)10
Conduit
Vein (any level)
Above-knee PTFE
Below-knee PTFE
Primary patencyat S years
66%
47%
33%
Table 50: Summary: below-knee femoropopliteal grafts"?
Conduit
Reverse saphenous vein
In situ vein bypass
Human Umbilical Vein
Polyretrafluoroethylene (l'TFE)
Primary patency at 4 years
77%
68%
60%
40%
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D4.9 Infrainguinal Disease-Endovascular Treatment
As with other interventions for CLI, the purpose of PTA is to salvage a functioning foot. Late
restenosis or occlusion after PTA may result in recurrent ulceration in some patients,' but it
rarely precludes subsequent surgery or compromises additional vascular segments. PTA can spare
saphenous vein for later use in the ipsilateral limb, the contralateral limb, or the coronary circu-
lation.
The categorical indications for endovascular treatment, based on clinical symptoms, include
patients in the grade I (severe claudication) grade II (rest pain ), and grade III (tissue loss) of the
Rutherford classification. For limb salvage indications, the effectiveness of transluminal angio-
plasry of the femoropopliteal arteries and the tib ioperoneal arteries should be considered togeth-
er rather than separately. This is because most patients with rest pain and tissue loss will have
multisegment occlusive disease, and effective treatment of both segments may be necessar y to
alleviate signs and symptoms.2,3 Furthermore, effective restoration of tibioperoncal artery blood
flow is believed by some to increase the durability of fernoropopliteal artery angioplasty.v
Unfortunately, few series have analyzed PTA of the fernoropopliteal and tibial segments togeth-
er.5,6,7 Angioplasry techniques have improved with time, allowing for technically successful per-
cutaneous recanalization of virtually all short lesions .8,9,10 However, appropriate selection of
anatomically suitable lesions remains the key to achieving acceptable results in patients with
infrainguinal occlusive disease and chronic limb-threatening ischemia (sec Recommendation 34,
p 5104).
